Related Experiment Video
Updated: Apr 28, 2026

08:39
Murine Colitis Modeling using Dextran Sulfate Sodium DSS
Published on: January 19, 2010
50.0K
Unveiling Colitis: A Journey through the Dextran Sodium Sulfate-induced Model
Chunhua Yang1,2, Didier Merlin1,2
1Institute for Biomedical Sciences, Digestive Disease Research Group, Georgia State University, Atlanta, GA, 30303, USA.
Inflammatory Bowel Diseases
|January 27, 2024
Summary
The dextran sodium sulfate (DSS)-induced colitis model is a key tool for studying inflammatory bowel disease (IBD) and ulcerative colitis (UC) treatments. While valuable, researchers must consider its limitations for direct human application.
Area of Science:
- Gastroenterology
- Immunology
- Preclinical Research
Background:
- Inflammatory bowel disease (IBD), including ulcerative colitis (UC), requires robust animal models for pathogenesis research and therapeutic evaluation.
- The dextran sodium sulfate (DSS)-induced colitis model is widely utilized due to its reproducibility and ability to mimic human IBD features.
- This model is increasingly employed to explore the influence of gut microbiota, diet, and genetics on IBD.
Purpose of the Study:
- To comprehensively review factors contributing to DSS-induced colitis pathogenesis.
- To discuss critical considerations for the translational application of DSS-induced colitis research findings to human ulcerative colitis.
Main Methods:
- Literature review of studies utilizing the DSS-induced colitis model.
- Analysis of factors influencing colitis severity and pathogenesis in preclinical settings.
- Evaluation of the model's strengths and limitations in mimicking human IBD.
Main Results:
- The DSS model is highly reproducible, easy to manage, and reflects key aspects of human IBD.
- It facilitates investigation into microbiota, diet, and genetic influences on colitis.
- Despite its utility, the DSS model is not a perfect replica of human colitis, necessitating careful interpretation of results.
Conclusions:
- The DSS-induced colitis model is an indispensable preclinical tool for IBD research.
- Understanding the factors influencing this model and its translational limitations is crucial for advancing IBD therapeutics.
- Further research should focus on bridging the gap between animal model findings and human clinical outcomes in IBD.

